Search

Search Constraints

You searched for: Author/Creator Hoogendoorn, M.

Search Results

2. Bridging the gap between the randomised clinical trial world and the real world by combination of population-based registry and electronic health record data: A case study in haemato-oncology. (November 2017)

4. PROTEOMICS MARKERS PROGNOSTIC FOR OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER TREATMENT: RESULTS FROM THE HOVON‐109 STUDY. (12th June 2019)

5. RITUXIMAB MAINTENANCE FOR PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA IN FIRST COMPLETE REMISSION: RESULTS FROM A RANDOMIZED HOVON‐NORDIC LYMPHOMA GROUP PHASE III STUDY. (12th June 2019)

6. S125: 10-DAY DECITABINE VS. CONVENTIONAL CHEMOTHERAPY ("3 + 7") FOLLOWED BY ALLOGRAFTING (HSCT) IN AML PATIENTS ≥60 YEARS: A RANDOMIZED PHASE III STUDY OF THE EORTC LEUKEMIA GROUP, GIMEMA, CELG, AND GMDS-SG. (23rd June 2022)

9. Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study. Issue 11 (18th September 2020)

10. Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study. Issue 11 (18th September 2020)